| |
| |
|
| Insider
Information: |
Tatsis Ourania |
| Relationship: |
EVP, Chief Reg. & Qual... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
49,098 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$23,642,160 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,098 |
|
|
| Total
Value |
$23,642,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Reg. & Qual... |
2024-06-03 |
49,098 |
2019-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,114 |
70,593 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$887,754 |
D/D |
(2,100) |
68,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-12 |
4 |
AS |
$420.24 |
$131,955 |
D/D |
(314) |
68,179 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
63,680 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
60,307 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-20 |
4 |
AS |
$420.79 |
$201,979 |
D/D |
(480) |
59,827 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-21 |
4 |
AS |
$421.77 |
$151,837 |
D/D |
(360) |
59,467 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$1,428,793 |
D/D |
(3,309) |
56,158 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-26 |
4 |
AS |
$425.70 |
$150,698 |
D/D |
(354) |
55,804 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-05-30 |
4 |
AS |
$439.11 |
$1,031,909 |
D/D |
(2,350) |
53,523 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-05-31 |
4 |
AS |
$445.00 |
$1,001,250 |
D/D |
(2,250) |
51,273 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-06-03 |
4 |
AS |
$460.00 |
$1,000,500 |
D/D |
(2,175) |
49,098 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Regulatory Officer |
• – – |
2020-05-06 |
4 |
AS |
$268.80 |
$263,431 |
D/D |
(966) |
12,738 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Regulatory Officer |
• – – |
2020-05-06 |
4 |
OE |
$155.57 |
$168,146 |
D/D |
966 |
13,704 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Regulatory Officer |
• – – |
2020-05-15 |
4 |
AS |
$276.35 |
$34,080 |
D/D |
(120) |
12,738 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2019-10-01 |
4 |
AS |
$169.11 |
$31,793 |
D/D |
(188) |
7,696 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2019-10-02 |
4 |
AS |
$167.69 |
$74,454 |
D/D |
(444) |
7,252 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2019-11-15 |
4 |
AS |
$205.95 |
$1,030 |
D/D |
(5) |
7,252 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-01-08 |
4 |
OE |
$187.53 |
$314,113 |
D/D |
1,675 |
8,927 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-01-08 |
4 |
AS |
$227.53 |
$381,113 |
D/D |
(1,675) |
7,252 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,694 |
16,946 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-06 |
4 |
OE |
$155.57 |
$168,302 |
D/D |
967 |
17,913 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-06 |
4 |
AS |
$238.77 |
$231,527 |
D/D |
(967) |
16,946 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-17 |
4 |
D |
$241.50 |
$144,176 |
D/D |
(597) |
16,349 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-18 |
4 |
AS |
$241.82 |
$311,585 |
D/D |
(1,279) |
15,070 |
0 |
% |
|
53 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
